• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jupiter Neurosciences, Inc. - Common Stock (NQ:JUNS)

0.2708 +0.0658 (+32.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 79,176,726
Open 0.2304
Bid (Size) 0.2540 (300)
Ask (Size) 0.2549 (500)
Prev. Close 0.2050
Today's Range 0.2300 - 0.2849
52wk Range 0.1721 - 3.330
Shares Outstanding 34,426,355
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's after hours session ↗
May 21, 2026
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
May 21, 2026
Via Chartmill

Performance

YTD
-73.2%
-73.2%
1 Month
-41.8%
-41.8%
3 Month
-51.4%
-51.4%
6 Month
-78.0%
-78.0%
1 Year
-50.9%
-50.9%

More News

Read More
Most active stocks in Wednesday's session ↗
May 20, 2026
Via Chartmill
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
May 20, 2026
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
May 20, 2026
Via Chartmill
Top movers in Monday's pre-market session ↗
April 20, 2026
Via Chartmill
News headline image
Jupiter Neurosciences Investor News: Rosen Law Firm Encourages Jupiter Neurosciences, Inc. Investors to Inquire About Securities Class Action Investigation – JUNS
April 13, 2026
From Rosen Law Firm
Via Business Wire
News headline image
Rosen Law Firm Encourages Jupiter Neurosciences, Inc. Investors to Inquire About Securities Class Action Investigation – JUNS
April 12, 2026
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
March 13, 2026
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
March 10, 2026
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Jupiter Neurosciences Selected as B2i Digital Featured Company
February 12, 2026
Via NewMediaWire
News headline image
Jupiter Neurosciences Selected as B2i Digital Featured Company
February 12, 2026
Via TheNewswire.com
Unusual volume stocks in Thursday's session ↗
January 29, 2026
Via Chartmill
News headline image
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon
December 16, 2025
Via NewMediaWire
News headline image
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon
December 16, 2025
Via TheNewswire.com
News headline image
Jupiter Neurosciences Brings Its Brain Health Expertise To The Masses With Nugevia - And A Range Of Celebs From Athletes To Scientists Are Customers
November 06, 2025
Via NewMediaWire
News headline image
Jupiter Neurosciences Brings Its Brain Health Expertise To The Masses With Nugevia - And A Range Of Celebs From Athletes To Scientists Are Customers
November 06, 2025
Via TheNewswire.com
News headline image
Jupiter Neurosciences CEO And President Talk About The Power of JOTROL And The Launch of Its Longevity Consumer Line With Benzinga
August 21, 2025
Via TheNewswire.com
News headline image
Jupiter Neurosciences CEO And President Talk About The Power of JOTROL And The Launch of Its Longevity Consumer Line With Benzinga
August 21, 2025
Via NewMediaWire
News headline image
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia(TM) Brand
August 19, 2025
Via NewMediaWire
News headline image
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia(TM) Brand
August 19, 2025
Via TheNewswire.com
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
August 14, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
July 17, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
July 11, 2025
Via Benzinga
News headline image
From Fighting Inflammation To Regenerating Cells: How Jupiter Neurosciences Is Putting The Pep Back In Our Step As We Age
July 10, 2025
Via NewMediaWire

Frequently Asked Questions

Is Jupiter Neurosciences, Inc. - Common Stock publicly traded?
Yes, Jupiter Neurosciences, Inc. - Common Stock is publicly traded.
What exchange does Jupiter Neurosciences, Inc. - Common Stock trade on?
Jupiter Neurosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Jupiter Neurosciences, Inc. - Common Stock?
The ticker symbol for Jupiter Neurosciences, Inc. - Common Stock is JUNS on the Nasdaq Stock Market
What is the current price of Jupiter Neurosciences, Inc. - Common Stock?
The current price of Jupiter Neurosciences, Inc. - Common Stock is 0.2708
When was Jupiter Neurosciences, Inc. - Common Stock last traded?
The last trade of Jupiter Neurosciences, Inc. - Common Stock was at 05/21/26 04:00 PM ET
What is the market capitalization of Jupiter Neurosciences, Inc. - Common Stock?
The market capitalization of Jupiter Neurosciences, Inc. - Common Stock is 9.32M
How many shares of Jupiter Neurosciences, Inc. - Common Stock are outstanding?
Jupiter Neurosciences, Inc. - Common Stock has 9M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap